CD40LG and infection: The eligible study included for IgM ELISA accuracy analysis [41] was conducted in France, French Polynesia, Guadeloupe, Guyana, and Martinique, and was a two-gate design study that included patients with suspected leptospirosis and controls from patients with evidence of recent infection for dengue and syphilis, or from healthy blood donors.